Skip to content

Insider · CIK 0001668351

Judy Krandel

directorcfoofficer

Files at NEPH (NEPHROS INC), BEEM (Beam Global). First filing -, latest -.

In brief

Judy Krandel files SEC Form 4 as director and CFO at NEPH (NEPHROS INC), and also at BEEM (Beam Global). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Judy Krandel has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 23, 2026NEPH
NEPHROS INC
MOption exercise
Common Stock
+68,861$1.71$118k68,861Mar 25, 2026
Mar 23, 2026NEPH
NEPHROS INC
MOption exercise
Stock Option (right to buy)derivative
-68,861$0.00$053,663Mar 25, 2026
Mar 16, 2026NEPH
NEPHROS INC
AGrant or award
Stock Option (right to buy)derivative
+4,000$0.00$04,000Mar 18, 2026
Jan 6, 2026BEEM
Beam Global
AGrant or award
Common Stock
+71,577$1.75$125k133,019Jan 7, 2026
Mar 27, 2025NEPH
NEPHROS INC
AGrant or award
Stock Option (right to buy)derivative
+54,359$0.00$054,359Mar 31, 2025
Jan 2, 2025BEEM
Beam Global
AGrant or award
Common Stock
+40,453$3.09$125k61,443Jan 31, 2025
Dec 4, 2023BEEM
Beam Global
AGrant or award
Common Stock
+828$5.50$4,5547,328Dec 7, 2023
Nov 1, 2023NEPH
NEPHROS INC
AGrant or award
Stock Option (right to buy)derivative
+122,524$0.00$0122,524Nov 3, 2023

Questions about Judy Krandel

Answered from the filings on this page, as of the latest one.

Is Judy Krandel buying or selling?

Judy Krandel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Judy Krandel's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Judy Krandel has 0.

Where does Judy Krandel file Form 4?

Judy Krandel has filed Form 4 at NEPH (NEPHROS INC) as Chief Financial Officer; BEEM (Beam Global). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Judy Krandel: insider trades and track record | InsiderTell